Home › Upcoming votes › Rafael Holdings, Inc.
Prior-year votes at Rafael Holdings, Inc. → 2025-2026 season, in the search
Read the proxy statement on EDGAR
Summary, checked against the proxy statement. Each point is backed by a passage of the filing, shown under the point; figures under “Last year’s votes” come from the company’s Form 8-K. Read the proxy statement before relying on it.
Annual meeting: six directors, auditor ratification, an amendment and restatement of the 2021 Equity Incentive Plan, and an advisory vote on executive pay.
“3. To approve an amendment and restatement of the Rafael Holdings, Inc. 2021 Equity Incentive Plan that will increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder by 2,422,483.” Find it in the filing
“the maximum number of Shares that may be issued in respect of Awards under the Plan is 6,788,278 Shares.” Find it in the filing
“(i) options to purchase 728,170 shares of the Company's Class B common stock to Howard Jonas; (ii) options to purchase 390,000 shares of the Company's Class B common stock to Joshua Fine; and (iii) options to purchase 165,000 shares of the Company's Class B common stock to David Polinsky.” Find it in the filing
“Fifty percent (50%) of the options will vest upon both an Food and Drug Administration ("FDA") approval of TrappsolĀ® CycloTM (remibetadex) and issuance to the Company (or a subsidiary) of a priority review voucher;” Find it in the filing
“The options were granted on August 18, 2026 and if FDA approval is not obtained by August 12, 2027, the options will be forfeited and rendered null and void.” Find it in the filing
“All six voting members are standing for re-election at the Annual Meeting.” Find it in the filing
“Mr. Fine's term as an ex-officio member of the Board of Directors expires at the Annual Meeting.” Find it in the filing
“4. To conduct an advisory vote on compensation of named executive officers.” Find it in the filing
Last year’s proxy statement, page 2: “4. To transact other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.”
“3. To approve an amendment and restatement of the Rafael Holdings, Inc. 2021 Equity Incentive Plan that will increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder by 2,422,483.” Find it in the filing
Last year’s proxy statement, page 2: “3. To approve an amendment to the Rafael Holdings, Inc. 2021 Equity Incentive Plan that will increase the number of shares of the Company's Class B Common Stock available for the grant of awards thereunder by 1,000,000.”
“The Nominating Committee held two meetings during Fiscal 2026.” Find it in the filing
Last year’s proxy statement, page 11: “The Nominating Committee held five meetings during Fiscal 2025.”
Ballot read from the proxy statement and checked. As listed in Rafael Holdings, Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For | 6 nominees; support 97% to 99.6% |
| 2 | RATIFICATION OF THE APPOINTMENT OF COHNREZNICK LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JULY 31, 2027 Auditor |
Board | For | 99.4% support |
| 3 | APPROVAL OF AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2021 EQUITY INCENTIVE PLAN | Board | For | — |
| 4 | ADVISORY VOTE ON EXECUTIVE COMPENSATION Say on pay |
Board | For | — |
From Rafael Holdings, Inc.’s Form 8-K, filed January 12, 2026, for the meeting held January 8, 2026 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Susan Y. Bernstein | 99.6% | Elected |
| Elect Director: Alan Grayson | 99.6% | Elected |
| Elect Director: Howard S. Jonas | 99% | Elected |
| Elect Director: Markus W. Sieger | 99.6% | Elected |
| Elect Director: Mark N. Stein | 99% | Elected |
| Elect Director: Michael J. Weiss | 97% | Elected |
| 2. A majority of the votes present or represented at the Meeting by the holders of shares entitled to vote on the following matter were vote | 99.4% | — |
| 3. A majority of the votes present or represented at the Meeting by the holders of shares entitled to vote on the following matter were vote | 95% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.